BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Prašek M, Pavković P, Knotek M. Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria. Clin Biochem 2012;45:1694-6. [PMID: 22968085 DOI: 10.1016/j.clinbiochem.2012.07.115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Jesudason D, Pedersen E, Clifton P. Utility of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in obese diabetic individuals before and after weight loss. Am J Kidney Dis 2014;64:159-61. [PMID: 24685063 DOI: 10.1053/j.ajkd.2014.02.014] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Bulum T, Tomić M, Duvnjak L. Serum bilirubin levels are negatively associated with diabetic retinopathy in patients with type 1 diabetes and normal renal function. Int Ophthalmol 2018;38:1095-101. [PMID: 28523523 DOI: 10.1007/s10792-017-0565-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
3 Bulum T, Blaslov K, Duvnjak L. Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy. Semin Ophthalmol 2016;31:198-202. [PMID: 24785685 DOI: 10.3109/08820538.2014.912338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
4 Wu J, Geng J, Liu L, Teng W, Chen L. The Relationship between Estimated Glomerular Filtration Rate and Diabetic Retinopathy. J Ophthalmol. 2015;2015:326209. [PMID: 25866672 DOI: 10.1155/2015/326209] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
5 Lingli X, Qing Z, Wenfang X. Diagnostic value of the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations in diabetic patients: a systematic review and meta-analysis. J Int Med Res 2020;48:300060520925950. [PMID: 32589856 DOI: 10.1177/0300060520925950] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Duvnjak L, Blaslov K, Perković MN, Ćuća JK. Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes. Endocrine 2016;53:453-8. [PMID: 26906712 DOI: 10.1007/s12020-016-0899-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Pérez-López L, Boronat M, Melián C, Brito-Casillas Y, Wägner AM. Animal Models and Renal Biomarkers of Diabetic Nephropathy. Adv Exp Med Biol 2021;1307:521-51. [PMID: 32329028 DOI: 10.1007/5584_2020_527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bondor CI, Potra AR, Rusu CC, Moldovan D, Bolboacă SD, Kacso IM. RELATIONSHIP OF OXIDATIVE STRESS TO URINARY ANGIOTENSIN CONVERTING ENZYME 2 IN TYPE 2 DIABETES MELLITUS PATIENTS. Acta Endocrinol (Buchar) 2016;12:150-6. [PMID: 31149080 DOI: 10.4183/aeb.2016.150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Tomić M, Vrabec R, Ljubić S, Bulum T, Rahelić D. Plasma homocysteine is associated with nonproliferative retinopathy in patients with type 2 diabetes without renal disease. Diabetes Metab Syndr 2021;16:102355. [PMID: 34920196 DOI: 10.1016/j.dsx.2021.102355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cocozza S, Russo C, Pisani A, Olivo G, Riccio E, Cervo A, Pontillo G, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Mignani R, Borrelli P, Imbriaco M, Brunetti A, Tedeschi E, Palma G. Redefining the Pulvinar Sign in Fabry Disease. AJNR Am J Neuroradiol 2017;38:2264-9. [PMID: 29051208 DOI: 10.3174/ajnr.A5420] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
11 Blaslov K, Bulum T, Duvnjak L. Waist-to-height ratio is independently associated with chronic kidney disease in overweight type 2 diabetic patients. Endocr Res 2015;40:194-8. [PMID: 25536141 DOI: 10.3109/07435800.2014.987868] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Blaslov K, Bulum T, Duvnjak L. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients. Journal of Diabetes and its Complications 2015;29:390-4. [DOI: 10.1016/j.jdiacomp.2014.12.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Wood AJ, Churilov L, Perera N, Thomas D, Poon A, Macisaac RJ, Jerums G, Ekinci EI. Estimating glomerular filtration rate: Performance of the CKD-EPI equation over time in patients with type 2 diabetes. Journal of Diabetes and its Complications 2016;30:49-54. [DOI: 10.1016/j.jdiacomp.2015.08.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
14 Lovrenčić MV, Biljak VR, Blaslov K, Božičević S, Duvnjak LS. Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. World J Diabetes 2017; 8(5): 222-229 [PMID: 28572883 DOI: 10.4239/wjd.v8.i5.222] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Cachat F, Combescure C, Cauderay M, Girardin E, Chehade H. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clin J Am Soc Nephrol. 2015;10:382-389. [PMID: 25568216 DOI: 10.2215/cjn.03080314] [Cited by in Crossref: 80] [Cited by in F6Publishing: 43] [Article Influence: 11.4] [Reference Citation Analysis]
16 Cocozza S, Olivo G, Riccio E, Russo C, Pontillo G, Ugga L, Migliaccio S, de Rosa D, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Tuttolomondo A, Caronia A, Russo CV, Lanzillo R, Brescia Morra V, Imbriaco M, Brunetti A, Tedeschi E, Pisani A. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis. Neuroradiology 2017;59:563-70. [DOI: 10.1007/s00234-017-1829-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
17 Liew A, Bavanandan S, Prasad N, Wong MG, Chang JM, Eiam-Ong S, Hao CM, Lim CY, Lim SK, Oh KH, Okada H, Susantitaphong P, Lydia A, Tran HTB, Villanueva R, Yeo SC, Tang SCW. ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE. Nephrology (Carlton) 2020;25 Suppl 2:12-45. [PMID: 33111477 DOI: 10.1111/nep.13785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Bulum T, Tomić M, Duvnjak L. Total Serum Cholesterol Increases Risk for Development and Progression of Nonproliferative Retinopathy in Patients with Type 1 Diabetes Without Therapeutic Intervention: Prospective, Observational Study. Arch Med Res 2017;48:467-71. [PMID: 29089151 DOI: 10.1016/j.arcmed.2017.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
19 Wu CZ, Chang LC, Lin YF, Hung YJ, Pei D, Chu NF, Chen JS. Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy. Clin Biochem 2015;48:1324-9. [PMID: 26162494 DOI: 10.1016/j.clinbiochem.2015.07.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
20 Biljak VR, Honović L, Matica J, Krešić B, Vojak SŠ. The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations. Biochem Med (Zagreb) 2017;27:153-76. [PMID: 28392738 DOI: 10.11613/BM.2017.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
21 Duvnjak L, Perković MN, Blaslov K. Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes. J Diabetes Complications 2017;31:218-22. [PMID: 27625045 DOI: 10.1016/j.jdiacomp.2016.08.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
22 Franzén S, Friederich-persson M, Fasching A, Hansell P, Nangaku M, Palm F. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes. American Journal of Physiology-Renal Physiology 2014;306:F1171-8. [DOI: 10.1152/ajprenal.00595.2013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
23 Bulum T, Vučić Lovrenčić M, Tomić M, Vučković-Rebrina S, Roso V, Kolarić B, Vuksan V, Duvnjak L. Serum adipocytokines are associated with microalbuminuria in patients with type 1 diabetes and incipient chronic complications. Diabetes Metab Syndr 2019;13:496-9. [PMID: 30641752 DOI: 10.1016/j.dsx.2018.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
24 Bulum T, Blaslov K, Duvnjak L. Risk factors for development and progression of nonproliferative retinopathy in normoalbuminuric patients with type 1 diabetes. Diabetes Res Clin Pract 2014;106:555-9. [PMID: 25451889 DOI: 10.1016/j.diabres.2014.09.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Pisani A, Petruzzelli Annicchiarico L, Pellegrino A, Bruzzese D, Feriozzi S, Imbriaco M, Tedeschi E, Cocozza S, De Rosa D, Mignani R, Veroux M, Battaglia Y, Concolino D, Sestito S, Pieruzzi F, Caroti L, Manna R, Zizzo C, Santangelo M, Sabbatini M, Riccio E. Parapelvic cysts, a distinguishing feature of renal Fabry disease. Nephrol Dial Transplant 2018;33:318-23. [PMID: 28371803 DOI: 10.1093/ndt/gfx009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]